首页> 美国卫生研究院文献>Journal of the International AIDS Society >Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre

【2h】

Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre

机译：在一群有治疗经验的HIV阳性患者中转用拉米夫定加darunavir / r双重疗法：意大利中心的经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionAccording to recent evidence about boosted protease inhibitors (PIs/r)-simplified regimens, the combination of 3TC and DRV/r 800/100 mg could represent a feasible option for optimizing antiretroviral therapy (ART) in treatment-experienced HIV+ patients.

机译：引言根据有关加强蛋白酶抑制剂（PIs / r）简化疗法的最新证据，3TC和DRV / r 800/100 mg的组合可能是优化有治疗经验的HIV +患者抗逆转录病毒疗法（ART）的可行选择。

著录项

期刊名称 Journal of the International AIDS Society
作者
Alberto Borghetti; Annalisa Mondi; Benedetta Piccoli; Roberta Gagliardini; Silvia Lamonica; Nicoletta Ciccarelli; Alessandro DAvino; Federico Pallavicini; Roberto Cauda; Andrea De Luca; Massimiliano Fabbiani; Simona Di Giambenedetto;
展开▼
作者单位

展开▼
年(卷),期 2014(17),4Suppl 3
年度 2014
页码 19817
总页数 1
原文格式 PDF
正文语种
中图分类免疫学;病毒传染病;
关键词

相似文献

外文文献
中文文献
专利

1. 改良的XELOX辅助疗法治疗Ⅲ期结肠癌术后患者的安全性和疗效:一项中国单中心经验 [J] . 彭健宏, 李伟豪, 张荣欣, 癌症（英文版） . 2020,第005期
2. Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre [J] . Alberto Borghetti, Annalisa Mondi, Benedetta Piccoli, Journal of the International Aids Society . 2014,第4Suppla3期

机译：在一群有治疗经验的HIV阳性患者中转用拉米夫定加darunavir / r双重疗法：意大利中心的经验
3. Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [J] . Umberto Restelli, Massimiliano Fabbiani, Simona Di Giambenedetto, ClinicoEconomics and Outcomes Research . 2017,第6期

机译：从Atlas-M试验数据开始，对意大利接受基于Atazanavir的三联疗法的HIV阳性患者简化为Atazanavir +利托那韦+拉米夫定双重疗法的预算影响分析的更新
4. Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [J] . Umberto Restelli, Massimiliano Fabbiani, Simona Di Giambenedetto, ClinicoEconomics and Outcomes Research . 2017,第10期

机译：从Atlas-M试验数据开始，对在意大利接受基于Atazanavir的三联疗法的HIV阳性患者简化为Atazanavir + ritonavir +拉米夫定双重疗法的预算影响分析
5. Photodynamic therapy of oral candidiasis in hiv-positive patients [C] . Cadastro G., Giovani E. International Congress of Chemotherapy and Infection . 2009

机译：艾滋病毒阳性患者口腔念珠菌病的光动力学治疗
6. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
7. Effectiveness Safety and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus [O] . Sang-Ah Lee, Shin-Woo Kim, Hyun-Ha Chang, 2018

机译：接受Dolutegravir加Cobicistat加强治疗的Darunavir双重治疗的经验人类免疫缺陷病毒患者的有效性安全性和耐受性
8. Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre [O] . Alberto Borghetti, Annalisa Mondi, Benedetta Piccoli, 2014

机译：在一组经历过治疗的HIV阳性患者中改用拉米夫定加darunavir / r双重治疗：意大利中心的经验

Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre

摘要

著录项

相似文献

相关主题

期刊订阅